Literature DB >> 27742543

Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA.

Zhikuan Zhang1, Umeharu Ohto1, Takuma Shibata2, Elena Krayukhina3, Masato Taoka4, Yoshio Yamauchi4, Hiromi Tanji1, Toshiaki Isobe4, Susumu Uchiyama5, Kensuke Miyake2, Toshiyuki Shimizu6.   

Abstract

Toll-like receptor 7 (TLR7) is a single-stranded RNA (ssRNA) sensor in innate immunity and also responds to guanosine and chemical ligands, such as imidazoquinoline compounds. However, TLR7 activation mechanism by these ligands remain largely unknown. Here, we generated crystal structures of three TLR7 complexes, and found that all formed an activated m-shaped dimer with two ligand-binding sites. The first site conserved in TLR7 and TLR8 was used for small ligand-binding essential for its activation. The second site spatially distinct from that of TLR8 was used for a ssRNA-binding that enhanced the affinity of the first-site ligands. The first site preferentially recognized guanosine and the second site specifically bound to uridine moieties in ssRNA. Our structural, biochemical, and mutagenesis studies indicated that TLR7 is a dual receptor for guanosine and uridine-containing ssRNA. Our findings have important implications for understanding of TLR7 function, as well as for therapeutic manipulation of TLR7 activation.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Toll-like receptor 7; X-ray crystallography; guanosine innate immunity; pattern-recognition receptor; single-stranded RNA; synergistic effect

Mesh:

Substances:

Year:  2016        PMID: 27742543     DOI: 10.1016/j.immuni.2016.09.011

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  127 in total

1.  DNA-based fluorescent probes of NOS2 activity in live brains.

Authors:  Aneesh T Veetil; Junyi Zou; Katharine W Henderson; Maulik S Jani; Shabana M Shaik; Sangram S Sisodia; Melina E Hale; Yamuna Krishnan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-17       Impact factor: 11.205

Review 2.  Trial Watch: Toll-like receptor agonists in cancer immunotherapy.

Authors:  Melody Smith; Elena García-Martínez; Michael R Pitter; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-10-11       Impact factor: 8.110

Review 3.  Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity.

Authors:  GuanQun Liu; Michaela U Gack
Journal:  Immunity       Date:  2020-07-14       Impact factor: 31.745

4.  TLR8 Is a Sensor of RNase T2 Degradation Products.

Authors:  Wilhelm Greulich; Mirko Wagner; Moritz M Gaidt; Che Stafford; Yiming Cheng; Andreas Linder; Thomas Carell; Veit Hornung
Journal:  Cell       Date:  2019-11-27       Impact factor: 41.582

Review 5.  Sequence-Specific Sensing of Nucleic Acids.

Authors:  Nicolas Vabret; Nina Bhardwaj; Benjamin D Greenbaum
Journal:  Trends Immunol       Date:  2016-11-14       Impact factor: 16.687

Review 6.  mRNA vaccines - a new era in vaccinology.

Authors:  Norbert Pardi; Michael J Hogan; Frederick W Porter; Drew Weissman
Journal:  Nat Rev Drug Discov       Date:  2018-01-12       Impact factor: 84.694

7.  Endosomal toll-like receptors play a key role in activation of primary human monocytes by cowpea mosaic virus.

Authors:  Marwah M Albakri; Frank A Veliz; Steven N Fiering; Nicole F Steinmetz; Scott F Sieg
Journal:  Immunology       Date:  2019-11-15       Impact factor: 7.397

8.  Toll-like Receptor 7 Contributes to Inflammation, Organ Injury, and Mortality in Murine Sepsis.

Authors:  Wenling Jian; Lili Gu; Brittney Williams; Yan Feng; Wei Chao; Lin Zou
Journal:  Anesthesiology       Date:  2019-07       Impact factor: 7.892

9.  Duplicated TLR5 of zebrafish functions as a heterodimeric receptor.

Authors:  Carlos G P Voogdt; Jaap A Wagenaar; Jos P M van Putten
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-19       Impact factor: 11.205

Review 10.  Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation.

Authors:  Mélanie Souyris; José E Mejía; Julie Chaumeil; Jean-Charles Guéry
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.